Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Favorable outcomes were higher for individuals with emphysema predominantly in the upper lobe with low baseline exercise capacity
Monitor Your Weight and Adjust Early Weigh yourself weekly during the transition off semaglutide and monthly once stable
When to contact a healthcare provider : Patients should seek medical advice if they experience: Severe or persistent abdominal pain, especially if radiating to the back (potential pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (potential gallbladder disease) Inability to pass gas or stool for more than 3 days Vomiting that prevents adequate hydration Signs of dehydration (dark urine, dizziness, decreased urination) Blood in stool or black, tarry stools Unintentional weight loss exceeding expected therapeutic effects New or worsening symptoms after several weeks of stable treatment Patients experiencing persistent gastrointestinal symptoms should discuss with their provider whether adjusting the tirzepatide dose escalation schedule or temporarily holding at a lower dose might improve tolerability while maintaining therapeutic benefits
[PMID: 28228077] PubMed record related to this compound for laboratory literature review
US$ 29.34
US$ 21.70
US$ 23.69
